Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Human PD-1 / PDCD1 Full Length Protein, His Tag

Programmed cell death protein 1 (PD-1) is also known as CD279 and PDCD1, is a type I membrane protein and is a member of the extended CD28/CTLA-4 family of T cell regulators. PDCD1 is expressed on the surface of activated T cells, B cells, macrophages, myeloid cells and a subset of thymocytes. PD-1 has two ligands, PD-L1 and PD-L2, which are members of the B7 family. PD-L1 is expressed on almost all murine tumor cell lines, including PA1 myeloma, P815 mastocytoma, and B16 melanoma upon treatment with IFN-γ. PD-L2 expression is more restricted and is expressed mainly by DCs and a few tumor lines. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, coligation of PD1 inhibits BCR-mediating signal by dephosphorylating key signal transducer. In vitro, treatment of anti-CD3 stimulated T cells with PD-L1-Ig results in reduced T cell proliferation and IFN-γ secretion. Monoclonal antibodies targeting PD-1 that boost the immune system are being developed for the treatment of cancer.

Product Specifications

Background

Programmed cell death protein 1 (PD-1) is also known as CD279 and PDCD1, is a type I membrane protein and is a member of the extended CD28/CTLA-4 family of T cell regulators. PDCD1 is expressed on the surface of activated T cells, B cells, macrophages, myeloid cells and a subset of thymocytes. PD-1 has two ligands, PD-L1 and PD-L2, which are members of the B7 family. PD-L1 is expressed on almost all murine tumor cell lines, including PA1 myeloma, P815 mastocytoma, and B16 melanoma upon treatment with IFN-γ. PD-L2 expression is more restricted and is expressed mainly by DCs and a few tumor lines. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway. In addition, coligation of PD1 inhibits BCR-mediating signal by dephosphorylating key signal transducer. In vitro, treatment of anti-CD3 stimulated T cells with PD-L1-Ig results in reduced T cell proliferation and IFN-γ secretion. Monoclonal antibodies targeting PD-1 that boost the immune system are being developed for the treatment of cancer.

Specifications

This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 30.7 kDa. The protein migrates as 40-120 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

Accession Number

Q15116-1

Expression Region

Leu 25 - Leu 288

Host

HEK293

Target

PD-1

Conjugation

Unconjugated

Tag

C-10xHis

Source

Human

Stability

-20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Endotoxin

1.0 EU per μg

Purity

80%

Bioactivity

Immobilized Human PD-1 Full Length, His Tag (Cat. No. PD1-H52H6) at 0.2 μg/mL (100 μL/well) can bind Nivolumab with a linear range of 0.4-3 ng/mL (QC tested).

Format

Powder

Buffer

50 mM Tris, 100 mM NaCl, pH8.0 with detergent

Additives

Trehalose

Molecular Weight

30.7 kDa

Additionnal Information

Please see 'Shipping-and-Payments' sheet. Website: https://www.acrobiosystems.com/support/shipping-and-payments

Shipping Conditions

RT

Storage Conditions

-20°C

Package Size

20ug*1

Host or Source

HEK293

Species

Human

Protein ID

Q15116-1

Preservative

Trehalose

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Rpl31 AAV siRNA Pooled Vector
41347164 1.0 µg

Rpl31 AAV siRNA Pooled Vector

Ask
View Details
UGCG (UDP-glucose Ceramide Glucosyltransferase, Ceramide Glucosyltransferase, GLCT1, GLCT-1, Glucosylceramide Synthase, GCS, UDP-glucose:N-acylsphingosine D-glucosyltransferase) (MaxLight 750)
MBS6236014-01 0.1 mL

UGCG (UDP-glucose Ceramide Glucosyltransferase, Ceramide Glucosyltransferase, GLCT1, GLCT-1, Glucosylceramide Synthase, GCS, UDP-glucose:N-acylsphingosine D-glucosyltransferase) (MaxLight 750)

Ask
View Details
UGCG (UDP-glucose Ceramide Glucosyltransferase, Ceramide Glucosyltransferase, GLCT1, GLCT-1, Glucosylceramide Synthase, GCS, UDP-glucose:N-acylsphingosine D-glucosyltransferase) (MaxLight 750)
MBS6236014-02 5x 0.1 mL

UGCG (UDP-glucose Ceramide Glucosyltransferase, Ceramide Glucosyltransferase, GLCT1, GLCT-1, Glucosylceramide Synthase, GCS, UDP-glucose:N-acylsphingosine D-glucosyltransferase) (MaxLight 750)

Ask
View Details
Lentiviral human MAGOHB sgRNA gene knockout kit - Lentiviral human MAGOHB sgRNA gene knockout kit (25)
GTR15394005 1 Vial

Lentiviral human MAGOHB sgRNA gene knockout kit - Lentiviral human MAGOHB sgRNA gene knockout kit (25)

Ask
View Details
FGF3 (NM_005247) Human Tagged Lenti ORF Clone
RC220125L2 10 µg

FGF3 (NM_005247) Human Tagged Lenti ORF Clone

Ask
View Details